ESPN news http://m.espn.go.com/nba/story?storyId=9765198, Los Angeles Lakers Kobe Bryant traveled to Germany to receive PRP Platelet Rich Plasma injection therapy. Kobe made major news by receiving this treatment for his ailing knee in 2011 that provided dramatic improvement. According to the report, Kobe has had this treatment on his knee and ankle, and returned for further treatment to promote healing and potentially extend his playing career. While many professional athletes like Kobe have received biologic based injections as PRP, these therapies are now available locally to everyday people with daily pain from arthritis including the spine, shoulder, hip, knee, wrist/hand & foot ankle. It worked on him in 2011, but a newer therapy for advanced tendon or cartilage disease is BMC Bone marrow concentrate, that utilizes the body’s own regenerative cells that are re-injected into painful joints or tendons on the same day. More data is needed to best determine which patient and which conditions are best candidates for these promising therapies; and I am working on it. Each and every patient for whom I perform a cellular orthopedic (stem cell) intervention becomes part of our database following HIPPA and FDA rules and guidelines.
On Monday and Tuesday, I travelled to Broomfield, Colorado to finalize the plans for the clinical trial IRB application concerning a next generation of stem cell therapies. I hope to start enrolling patients who meet the inclusion criteria by the end of this month; once we receive IRB approval. Your original story may begin now with less pain and more function without surgery as a major advance in the orthopedic care of the aging athlete. You don’t have to be a professional athlete nor do you have to travel outside the country to avail yourself of the most recent advances in Cellular Orthopedics. Your own bone marrow provides the necessary mesenchymal stem cell resource, that when concentrated, allows for a minimally invasive intervention to relieve pain, improve motion, enhance your recreational profile and potentially reverse or at least influence the progression of arthritis. We will announce the start up date on the Regenexx Web site and in this Blog. Until that time, we offer the most advanced menu of Regenerative Medical Care following FDA guidelines.